πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 27 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12208093

Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11629334

Methods of isolating T cells and T cell receptors having antigenic specificity for a cance

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11471460

Autophagy modulators for use in treating cancer

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11384139

Antibody targeting cell surface deposited complement protein C3d and use thereof

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11359204

Chimeric antigen receptors targeting B-cell maturation antigen

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11338032

Methods of preparing anti-human papillomavirus antigen T cells

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 19 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11311613

Development of agonist epitopes of the human papillomavirus

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11241436

Autophagy inducers for treatment of CNS conditions

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11077182

Methods of preparing anti-human papillomavirus antigen T cells

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10864252

Anti-SSX-2 T cell receptors and related materials and methods of use

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9809824

CpG oligonucleotide prodrugs, compositions thereof and associated therapeutic methods

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8673888

Depsipeptide for therapy of kidney cancer

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8198042

CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 12 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7368100

Backbone-substituted bifunctional DOTA ligands, complexes and compositions thereof, and me

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 06 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7271150

Modified growth hormone

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7259142

Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 21 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 16 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7247615

Peptide agonists of prostate-specific antigen and uses therefor

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7244724

Pyrrolobenzodiazepines

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7232887

Melanoma antigens and their use in diagnostic and therapeutic methods

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 19 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 14 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7226991

Phenylalanine derivatives

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7223844

Broadly cross-reactive neutralizing antibodies against human immunodeficiency virus select

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7208161

Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7205334

Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7201907

Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 10 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted